Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) released an overseas regulatory announcement on 25 August 2026, informing shareholders that its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, has published an announcement on the Shanghai Stock Exchange website (http://www.sse.com.cn/home/search/?webswd=688161).

The filing, made under Rule 13.10B of the Hong Kong Listing Rules, serves to synchronize information disclosure between Hong Kong and mainland Chinese markets. Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited have expressly disclaimed responsibility for the contents of WEIGAO GROUP’s notice.

The announcement was authorized by Chairman Long Jing and lists the current composition of the Board: Executive Directors Long Jing, Cong Rinan, Lu Junqiang and Wang Daoming; Non-executive Directors Chen Lin and Tang Zhengpeng; and Independent Non-executive Directors Li Guohui, Meng Hong, Li Qiang and Sun Heng.

Further details of the subsidiary’s disclosure can be accessed through the Shanghai Stock Exchange link provided above.